We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.14 | 2.10 | 2.18 | 2.20 | 2.19 | 2.19 | 604,698 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/7/2021 11:05 | What the change to your medication? It’s clearly not working | 1ultimate | |
30/7/2021 11:03 | 1ultimate, read back over , should have been done by now!. | the stinger | |
30/7/2021 10:56 | Hi Eva, is that £‘a worth or shares? Well done!! Stinger now that’s a big allegation to make against the company, it looks like your current medication 💊 isn’t working imho haha | 1ultimate | |
30/7/2021 10:45 | Adding 30,000 into IMM | eva_1989 | |
30/7/2021 10:19 | There is no P3.. all bull | the stinger | |
30/7/2021 10:18 | My further shorts incoming... 5p soon | the stinger | |
30/7/2021 09:40 | End July it was expected something from the FDA. Why is it the FDA are taking so long to get to an agreed position - it can't be due exclusively to COVID as they have been active in progressing other stuff. So is it a vested interest issue delaying matters because that interest is confident the IMM stuff works. If the view is that it doesn't work then surely the FDA would be quick to give an opinion. Always wise to have a 2nd thread to the bow so to speak and as there are other areas of the world they could have been pursuing, perhaps in a joint venture? | colsmith | |
30/7/2021 08:46 | Yes but all quiet on that front…. | nobbygnome | |
30/7/2021 08:42 | Are we still expecting news from FDA before month end? | chadders | |
30/7/2021 07:58 | Keep waiting | sicilian_kan | |
30/7/2021 07:53 | Waiting for 5p here | the stinger | |
30/7/2021 07:15 | But McCarthy as CEO? Oh dear…. | nobbygnome | |
30/7/2021 07:13 | Good news with the Board changes. As much as Dimitri contributed well, from the outset of Immupharma and in the original Lupuzor deal, he has been sidelined for 5 years or so. It was Tim McCarthy who brought in Lanstead who funded most of the last Phase 3. It was Tim Franklin who brought in Avion who are funding the next Phase 3. Almost all the recent presentations have been done by these guys with Dimitri in the background. IMM has also needed better NEDs for a number of reasons and we now have them. It wouldn’t surprise me to see a new Chief Scientific Officer soon too. All in my view very positive. We need the right people running the company. | sicilian_kan | |
23/7/2021 15:31 | Increasing my short shortly | the stinger | |
22/7/2021 21:21 | We shall see! | the stinger | |
22/7/2021 21:12 | Stinger see you at 15p, you might aswell throw your short money down the drain 😂😂 | 1ultimate | |
22/7/2021 20:50 | See you at 5p 1ultimate. No good news here, just same old. Worth a bet at 4 or 5p max. | the stinger | |
22/7/2021 16:28 | Hi Eva xxxx | halfbutt | |
22/7/2021 15:59 | Volume is building guys... something unusual. | eva_1989 | |
22/7/2021 11:41 | Only because the facts prove you wrong. Anyhow, you carry on with your agenda. And I'll carry on ignoring you. Over & out. | lord loads of lolly | |
22/7/2021 10:43 | Llol Unlike most posters I know, I regularly admit I'm wrong, including on this thread a couple of days ago. | nobbygnome | |
22/7/2021 10:40 | My short is ok.. can't see any thing positive here, hence 8.5p and falling. | the stinger | |
22/7/2021 09:16 | nobbygnome - I don't deny that. You're just one of those people who's always right about everything. | lord loads of lolly |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions